25 XP   0   0   10

Jiangzhong Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Jiangzhong Pharmaceutical Co Ltd together

PenkeI guess you are interested in Jiangzhong Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangzhong Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangzhong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangzhong Pharmaceutical Co Ltd.

Quick analysis of Jiangzhong Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Jiangzhong Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.27
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥7.11
Expected worth in 1 year
¥7.08
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥1.89
Return On Investment
6.9%

For what price can you sell your share?

Current Price per Share
¥27.42
Expected price per share
¥24.75 - ¥
How sure are you?
50%

1. Valuation of Jiangzhong Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥27.42

Intrinsic Value Per Share

¥17.68 - ¥50.12

Total Value Per Share

¥24.79 - ¥57.23

2. Growth of Jiangzhong Pharmaceutical Co Ltd (5 min.)




Is Jiangzhong Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$618.4m$641.3m-$1.6m-0.3%

How much money is Jiangzhong Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$24.4m$20.5m$3.8m15.8%
Net Profit Margin16.4%15.6%--

How much money comes from the company's main activities?

3. Financial Health of Jiangzhong Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Jiangzhong Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Jiangzhong Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangzhong Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Jiangzhong Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Jiangzhong Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangzhong Pharmaceutical Co Ltd is ¥27.42. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangzhong Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangzhong Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.11. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.48 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangzhong Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.040.1%0.030.1%0.030.1%0.030.1%
Usd Book Value Change Per Share-0.05-0.2%0.000.0%0.000.0%0.010.0%0.010.0%
Usd Dividend Per Share0.080.3%0.070.2%0.060.2%0.040.1%0.030.1%
Usd Total Gains Per Share0.030.1%0.070.2%0.060.2%0.050.2%0.040.2%
Usd Price Per Share2.89-2.85-1.95-2.01-2.88-
Price to Earnings Ratio27.65-19.84-16.84-18.43-33.66-
Price-to-Total Gains Ratio90.70-63.28-53.63-56.29-973.49-
Price to Book Ratio2.94-2.81-1.92-2.12-4.50-
Price-to-Total Gains Ratio90.70-63.28-53.63-56.29-973.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.789444
Number of shares263
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.04
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.070.05
Gains per Quarter (263 shares)17.1813.96
Gains per Year (263 shares)68.7355.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
170-159421446
2140-21288328102
3210-319712542158
4279-426616756214
5349-633520971270
6419-740425085326
7489-847329299382
8559-9542334113438
9629-10611376127494
10698-11680417141550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.00.02.097.7%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%14.06.00.070.0%28.012.00.070.0%67.021.00.076.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.02.090.0%37.00.03.092.5%69.00.019.078.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%85.03.00.096.6%

Fundamentals of Jiangzhong Pharmaceutical Co Ltd

About Jiangzhong Pharmaceutical Co Ltd

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods. It offers OTC products for gastrointestinal digestion, upper respiratory tract, and supplements; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. The company sells its products under the Jiangzhong, Jiangzhong Lihuo, Chuyuan, Shenlingcao, Borlock, Yang Jisheng, and Sanghai brands. Jiang Zhong Pharmaceutical Co.,Ltd was founded in 1969 and is based in Nanchang, China.

Fundamental data was last updated by Penke on 2024-03-26 19:53:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangzhong Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangzhong Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.5% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 9.5%. The company is making a profit. +1
  • The TTM is 16.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ9.5%TTM16.4%-6.9%
TTM16.4%YOY15.6%+0.8%
TTM16.4%5Y18.1%-1.7%
5Y18.1%10Y18.9%-0.8%
1.1.2. Return on Assets

Shows how efficient Jiangzhong Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.9% Return on Assets means that Jiangzhong Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.8%-0.9%
TTM2.8%YOY2.5%+0.4%
TTM2.8%5Y2.6%+0.3%
5Y2.6%10Y2.8%-0.2%
1.1.3. Return on Equity

Shows how efficient Jiangzhong Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.1% Return on Equity means Jiangzhong Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 3.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM4.4%-1.3%
TTM4.4%YOY3.7%+0.7%
TTM4.4%5Y3.5%+0.9%
5Y3.5%10Y3.6%-0.1%

1.2. Operating Efficiency of Jiangzhong Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangzhong Pharmaceutical Co Ltd is operating .

  • Measures how much profit Jiangzhong Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.6%-10.6%
TTM10.6%YOY16.4%-5.8%
TTM10.6%5Y18.3%-7.8%
5Y18.3%10Y11.6%+6.8%
1.2.2. Operating Ratio

Measures how efficient Jiangzhong Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are ¥1.24 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 1.236. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.143. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.236TTM1.143+0.094
TTM1.143YOY1.176-0.033
TTM1.1435Y1.135+0.008
5Y1.13510Y0.770+0.364

1.3. Liquidity of Jiangzhong Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangzhong Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.51 means the company has ¥1.51 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 1.511. The company is able to pay all its short-term debts. +1
  • The TTM is 2.387. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.511TTM2.387-0.876
TTM2.387YOY2.983-0.596
TTM2.3875Y4.130-1.743
5Y4.13010Y2.524+1.606
1.3.2. Quick Ratio

Measures if Jiangzhong Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.19 means the company can pay off ¥0.19 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 0.190. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.522. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.522-0.332
TTM0.522YOY1.748-1.226
TTM0.5225Y2.135-1.613
5Y2.13510Y2.064+0.071

1.4. Solvency of Jiangzhong Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangzhong Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Jiangzhong Pharmaceutical Co Ltd assets are financed with 27.0% credit (debt) and the remaining percentage (100% - 27.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 0.270. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.255. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.255+0.015
TTM0.255YOY0.240+0.015
TTM0.2555Y0.188+0.067
5Y0.18810Y0.196-0.008
1.4.2. Debt to Equity Ratio

Measures if Jiangzhong Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 43.2% means that company has ¥0.43 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The MRQ is 0.432. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.397. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.432TTM0.397+0.034
TTM0.397YOY0.365+0.032
TTM0.3975Y0.269+0.128
5Y0.26910Y0.277-0.008

2. Market Valuation of Jiangzhong Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangzhong Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangzhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 27.65 means the investor is paying ¥27.65 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The EOD is 36.316. Based on the earnings, the company is overpriced. -1
  • The MRQ is 27.654. Based on the earnings, the company is overpriced. -1
  • The TTM is 19.839. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD36.316MRQ27.654+8.662
MRQ27.654TTM19.839+7.814
TTM19.839YOY16.843+2.996
TTM19.8395Y18.431+1.408
5Y18.43110Y33.658-15.227
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The EOD is 10.545. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.030. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 179.579. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.545MRQ8.030+2.515
MRQ8.030TTM179.579-171.549
TTM179.579YOY-9.913+189.492
TTM179.5795Y14.733+164.846
5Y14.73310Y-187.843+202.576
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangzhong Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jiangzhong Pharmaceutical Co Ltd:

  • The EOD is 3.857. Based on the equity, the company is fair priced.
  • The MRQ is 2.937. Based on the equity, the company is underpriced. +1
  • The TTM is 2.813. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.857MRQ2.937+0.920
MRQ2.937TTM2.813+0.124
TTM2.813YOY1.921+0.892
TTM2.8135Y2.116+0.697
5Y2.11610Y4.497-2.381
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangzhong Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.380-0.008-98%-0.033-91%0.097-492%0.093-509%
Book Value Per Share--7.1107.353-3%7.369-4%6.885+3%5.462+30%
Current Ratio--1.5112.387-37%2.983-49%4.130-63%2.524-40%
Debt To Asset Ratio--0.2700.255+6%0.240+12%0.188+43%0.196+38%
Debt To Equity Ratio--0.4320.397+9%0.365+18%0.269+60%0.277+56%
Dividend Per Share--0.6100.480+27%0.454+34%0.287+113%0.214+185%
Eps--0.1890.281-33%0.237-20%0.218-13%0.184+2%
Free Cash Flow Per Share--0.6500.328+98%0.266+144%0.267+144%0.282+131%
Free Cash Flow To Equity Per Share--0.6500.002+32434%-0.025+104%-0.005+101%0.122+433%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--50.118--------
Intrinsic Value_10Y_min--17.683--------
Intrinsic Value_1Y_max--1.737--------
Intrinsic Value_1Y_min--1.244--------
Intrinsic Value_3Y_max--7.723--------
Intrinsic Value_3Y_min--4.217--------
Intrinsic Value_5Y_max--16.727--------
Intrinsic Value_5Y_min--7.693--------
Market Cap17256338718.720+24%13142810723.04013003278959.885+1%8903292741.865+48%9177001341.392+43%13133001645.964+0%
Net Profit Margin--0.0950.164-42%0.156-39%0.181-48%0.189-50%
Operating Margin---0.106-100%0.164-100%0.183-100%0.116-100%
Operating Ratio--1.2361.143+8%1.176+5%1.135+9%0.770+60%
Pb Ratio3.857+24%2.9372.813+4%1.921+53%2.116+39%4.497-35%
Pe Ratio36.316+24%27.65419.839+39%16.843+64%18.431+50%33.658-18%
Price Per Share27.420+24%20.88020.658+1%14.138+48%14.573+43%20.864+0%
Price To Free Cash Flow Ratio10.545+24%8.030179.579-96%-9.913+223%14.733-45%-187.843+2439%
Price To Total Gains Ratio119.110+24%90.70163.277+43%53.627+69%56.286+61%973.490-91%
Quick Ratio--0.1900.522-64%1.748-89%2.135-91%2.064-91%
Return On Assets--0.0190.028-32%0.025-21%0.026-24%0.028-30%
Return On Equity--0.0310.044-30%0.037-16%0.035-13%0.036-15%
Total Gains Per Share--0.2300.473-51%0.421-45%0.384-40%0.307-25%
Usd Book Value--618459710.020639658278.254-3%641355429.546-4%599236677.498+3%475284666.669+30%
Usd Book Value Change Per Share---0.053-0.001-98%-0.005-91%0.013-492%0.013-509%
Usd Book Value Per Share--0.9831.016-3%1.018-4%0.952+3%0.755+30%
Usd Dividend Per Share--0.0840.066+27%0.063+34%0.040+113%0.030+185%
Usd Eps--0.0260.039-33%0.033-20%0.030-13%0.025+2%
Usd Free Cash Flow--56551844.45628573571.774+98%23160549.286+144%23222638.778+144%23886023.465+137%
Usd Free Cash Flow Per Share--0.0900.045+98%0.037+144%0.037+144%0.039+131%
Usd Free Cash Flow To Equity Per Share--0.0900.000+32434%-0.003+104%-0.001+101%0.017+433%
Usd Market Cap2384826010.927+24%1816336441.9241797053152.256+1%1230435056.926+48%1268261585.380+43%1814980827.472+0%
Usd Price Per Share3.789+24%2.8862.855+1%1.954+48%2.014+43%2.883+0%
Usd Profit--16420230.75024471472.039-33%20593828.385-20%18984350.150-14%16027654.737+2%
Usd Revenue--172755932.901151678023.374+14%131692214.191+31%110329027.609+57%91425469.751+89%
Usd Total Gains Per Share--0.0320.065-51%0.058-45%0.053-40%0.042-25%
 EOD+4 -4MRQTTM+13 -22YOY+12 -235Y+16 -1910Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Jiangzhong Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.316
Price to Book Ratio (EOD)Between0-13.857
Net Profit Margin (MRQ)Greater than00.095
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.190
Current Ratio (MRQ)Greater than11.511
Debt to Asset Ratio (MRQ)Less than10.270
Debt to Equity Ratio (MRQ)Less than10.432
Return on Equity (MRQ)Greater than0.150.031
Return on Assets (MRQ)Greater than0.050.019
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Jiangzhong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5078.515
Ma 20Greater thanMa 5024.048
Ma 50Greater thanMa 10023.319
Ma 100Greater thanMa 20022.298
OpenGreater thanClose26.490
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,128,543
Total Liabilities1,653,437
Total Stockholder Equity3,831,520
 As reported
Total Liabilities 1,653,437
Total Stockholder Equity+ 3,831,520
Total Assets = 6,128,543

Assets

Total Assets6,128,543
Total Current Assets2,397,130
Long-term Assets3,731,414
Total Current Assets
Cash And Cash Equivalents 1,332,929
Short-term Investments 50,015
Net Receivables 251,770
Inventory 406,167
Other Current Assets 4,196
Total Current Assets  (as reported)2,397,130
Total Current Assets  (calculated)2,045,077
+/- 352,053
Long-term Assets
Property Plant Equipment 1,597,483
Goodwill 41,742
Intangible Assets 401,103
Long-term Assets Other 1,513,112
Long-term Assets  (as reported)3,731,414
Long-term Assets  (calculated)3,553,440
+/- 177,974

Liabilities & Shareholders' Equity

Total Current Liabilities1,585,952
Long-term Liabilities67,484
Total Stockholder Equity3,831,520
Total Current Liabilities
Accounts payable 156,254
Other Current Liabilities 84,572
Total Current Liabilities  (as reported)1,585,952
Total Current Liabilities  (calculated)240,826
+/- 1,345,126
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,048
Long-term Liabilities  (as reported)67,484
Long-term Liabilities  (calculated)1,048
+/- 66,437
Total Stockholder Equity
Retained Earnings 2,437,289
Total Stockholder Equity (as reported)3,831,520
Total Stockholder Equity (calculated)2,437,289
+/- 1,394,231
Other
Capital Stock629,357
Common Stock Shares Outstanding 629,445
Net Invested Capital 3,831,520
Net Working Capital 811,177
Property Plant and Equipment Gross 1,597,483



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
716,203
708,467
665,905
639,272
709,683
696,934
702,728
740,781
867,242
948,249
933,117
986,939
985,952
1,128,087
1,227,199
1,164,554
1,287,510
1,273,045
1,222,614
1,151,334
1,221,876
1,197,062
1,228,152
1,318,571
1,332,649
1,254,597
1,319,792
1,221,858
1,429,196
1,337,898
1,624,363
1,586,146
1,777,444
1,532,169
1,735,403
1,597,658
1,726,488
1,705,755
1,836,012
2,506,018
2,422,373
2,217,145
2,673,803
2,588,820
2,857,818
2,599,321
2,788,334
3,228,866
3,355,612
2,958,810
2,937,566
2,992,397
3,085,794
3,227,330
3,190,734
3,327,010
3,349,323
3,206,905
3,332,682
2,678,298
2,906,651
2,854,458
2,845,759
3,065,747
3,008,409
3,011,937
3,210,535
3,364,102
3,444,639
3,466,309
3,564,462
3,816,972
4,376,404
4,358,473
4,505,320
4,759,194
4,691,593
4,690,504
4,793,102
4,923,574
5,058,291
5,130,123
5,147,518
5,997,600
6,093,177
5,957,127
6,153,455
6,243,659
6,316,949
6,169,640
6,239,723
6,128,543
6,128,5436,239,7236,169,6406,316,9496,243,6596,153,4555,957,1276,093,1775,997,6005,147,5185,130,1235,058,2914,923,5744,793,1024,690,5044,691,5934,759,1944,505,3204,358,4734,376,4043,816,9723,564,4623,466,3093,444,6393,364,1023,210,5353,011,9373,008,4093,065,7472,845,7592,854,4582,906,6512,678,2983,332,6823,206,9053,349,3233,327,0103,190,7343,227,3303,085,7942,992,3972,937,5662,958,8103,355,6123,228,8662,788,3342,599,3212,857,8182,588,8202,673,8032,217,1452,422,3732,506,0181,836,0121,705,7551,726,4881,597,6581,735,4031,532,1691,777,4441,586,1461,624,3631,337,8981,429,1961,221,8581,319,7921,254,5971,332,6491,318,5711,228,1521,197,0621,221,8761,151,3341,222,6141,273,0451,287,5101,164,5541,227,1991,128,087985,952986,939933,117948,249867,242740,781702,728696,934709,683639,272665,905708,467716,203
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,041,454
2,126,788
2,293,747
2,709,627
2,683,841
2,841,185
3,061,726
3,014,789
3,038,027
2,971,559
3,275,216
3,422,778
3,484,117
3,490,169
4,064,479
4,154,054
3,952,092
4,073,307
4,022,075
4,076,208
3,853,033
3,959,587
2,397,130
2,397,1303,959,5873,853,0334,076,2084,022,0754,073,3073,952,0924,154,0544,064,4793,490,1693,484,1173,422,7783,275,2162,971,5593,038,0273,014,7893,061,7262,841,1852,683,8412,709,6272,293,7472,126,7882,041,454000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
764,646
899,964
1,014,608
1,068,302
753,216
903,333
927,300
1,092,585
483,566
290,712
1,099,964
867,001
824,747
966,486
1,046,085
1,157,243
1,211,459
1,204,958
1,371,319
2,096,334
2,627,337
2,569,568
1,332,929
1,332,9292,569,5682,627,3372,096,3341,371,3191,204,9581,211,4591,157,2431,046,085966,486824,747867,0011,099,964290,712483,5661,092,585927,300903,333753,2161,068,3021,014,608899,964764,646000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
149,950
669,420
720,420
654,069
660,929
1,614,289
1,636,205
980,893
1,276,032
1,275,824
1,047,857
1,727,688
1,537,269
1,505,151
1,405,334
1,372,845
667,129
178,530
232,005
50,015
50,015232,005178,530667,1291,372,8451,405,3341,505,1511,537,2691,727,6881,047,8571,275,8241,276,032980,8931,636,2051,614,289660,929654,069720,420669,420149,950000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
269,245
185,164
233,577
146,925
205,290
200,202
204,571
129,269
269,531
184,835
177,446
212,715
163,348
161,812
245,055
206,786
262,320
238,638
182,836
130,242
196,170
189,244
206,458
280,139
281,618
268,701
326,453
225,108
302,148
285,240
292,893
368,884
357,113
244,384
362,539
287,170
256,253
302,547
299,482
451,386
260,000
161,491
459,429
529,380
514,303
469,802
581,263
524,446
682,301
583,314
525,359
606,152
803,810
797,787
805,235
1,064,102
857,292
961,404
761,510
900,965
812,696
695,392
390,889
569,666
604,959
740,731
741,916
993,673
882,747
1,061,047
883,842
1,080,855
222,978
172,257
180,555
1,161,790
1,038,257
671,521
797,200
914,042
996,559
984,398
917,949
841,596
1,030,101
795,037
1,001,625
801,875
852,978
617,626
262,628
251,770
251,770262,628617,626852,978801,8751,001,625795,0371,030,101841,596917,949984,398996,559914,042797,200671,5211,038,2571,161,790180,555172,257222,9781,080,855883,8421,061,047882,747993,673741,916740,731604,959569,666390,889695,392812,696900,965761,510961,404857,2921,064,102805,235797,787803,810606,152525,359583,314682,301524,446581,263469,802514,303529,380459,429161,491260,000451,386299,482302,547256,253287,170362,539244,384357,113368,884292,893285,240302,148225,108326,453268,701281,618280,139206,458189,244196,170130,242182,836238,638262,320206,786245,055161,812163,348212,715177,446184,835269,531129,269204,571200,202205,290146,925233,577185,164269,245
       Other Current Assets 
5,497
6,321
6,506
10,800
10,084
5,642
3,347
13,014
6,084
15,451
20,817
13,853
35,850
53,719
76,000
39,277
55,788
37,290
25,473
25,532
31,639
80,217
79,444
81,363
78,379
80,638
28,425
23,335
24,282
19,442
27,207
15,036
13,558
20,094
19,484
25,639
23,087
34,094
57,560
54,576
45,967
70,190
229,030
81,539
179,823
99,451
88,993
92,808
109,697
118,347
117,723
86,434
84,859
108,264
177,310
107,159
296,537
82,920
169,788
59,198
201,873
65,641
198,014
91,906
187,186
68,036
241,595
55,096
190,312
46,485
172,966
26,438
82,130
36,887
6,766
25,944
21,777
29,993
34,252
29,284
56,505
137,353
281,429
67,237
90,568
91,695
108,918
88,103
104,405
54,613
8,874
4,196
4,1968,87454,613104,40588,103108,91891,69590,56867,237281,429137,35356,50529,28434,25229,99321,77725,9446,76636,88782,13026,438172,96646,485190,31255,096241,59568,036187,18691,906198,01465,641201,87359,198169,78882,920296,537107,159177,310108,26484,85986,434117,723118,347109,69792,80888,99399,451179,82381,539229,03070,19045,96754,57657,56034,09423,08725,63919,48420,09413,55815,03627,20719,44224,28223,33528,42580,63878,37981,36379,44480,21731,63925,53225,47337,29055,78839,27776,00053,71935,85013,85320,81715,4516,08413,0143,3475,64210,08410,8006,5066,3215,497
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,666,777
1,674,632
1,664,135
1,697,467
1,676,805
1,652,477
1,821,543
1,648,358
1,635,513
1,646,006
1,657,349
1,933,121
1,939,124
2,005,035
2,080,148
2,221,584
2,240,741
2,316,607
2,280,136
3,731,414
3,731,4142,280,1362,316,6072,240,7412,221,5842,080,1482,005,0351,939,1241,933,1211,657,3491,646,0061,635,5131,648,3581,821,5431,652,4771,676,8051,697,4671,664,1351,674,6321,666,777000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
198,222
202,196
173,070
165,098
158,828
201,311
247,145
245,028
314,601
386,382
433,455
486,264
544,101
571,766
600,820
630,128
656,771
671,237
668,125
671,078
657,681
659,701
642,545
650,332
648,741
618,614
595,920
592,975
571,560
576,777
582,159
821,349
487,439
482,496
478,689
775,619
474,819
809,050
456,697
851,623
531,747
893,693
624,959
1,040,282
743,541
1,137,000
782,861
1,210,045
830,257
1,175,872
801,923
1,161,798
780,672
768,466
762,534
749,139
746,834
739,010
746,634
718,634
721,969
723,050
715,085
722,216
722,515
741,035
786,867
843,847
867,519
866,052
883,341
954,484
1,073,898
1,067,553
1,072,797
1,062,914
1,042,205
1,023,176
1,005,728
1,021,608
1,008,542
999,837
1,012,731
1,220,427
1,232,226
1,292,186
1,359,233
1,520,046
1,534,786
1,590,666
1,579,227
1,597,483
1,597,4831,579,2271,590,6661,534,7861,520,0461,359,2331,292,1861,232,2261,220,4271,012,731999,8371,008,5421,021,6081,005,7281,023,1761,042,2051,062,9141,072,7971,067,5531,073,898954,484883,341866,052867,519843,847786,867741,035722,515722,216715,085723,050721,969718,634746,634739,010746,834749,139762,534768,466780,6721,161,798801,9231,175,872830,2571,210,045782,8611,137,000743,5411,040,282624,959893,693531,747851,623456,697809,050474,819775,619478,689482,496487,439821,349582,159576,777571,560592,975595,920618,614648,741650,332642,545659,701657,681671,078668,125671,237656,771630,128600,820571,766544,101486,264433,455386,382314,601245,028247,145201,311158,828165,098173,070202,196198,222
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,837
17,792
17,792
14,776
14,776
14,776
14,776
14,776
14,776
14,776
14,776
41,742
41,742
41,742
41,742
41,742
41,742
41,742
41,742
41,742
41,74241,74241,74241,74241,74241,74241,74241,74241,74214,77614,77614,77614,77614,77614,77614,77614,77617,79217,79215,837000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184,497
182,366
192,918
191,498
206,225
206,519
218,274
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000218,274206,519206,225191,498192,918182,366184,497000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
3,298
4,495
4,533
4,370
10,324
10,091
11,155
10,065
11,000
10,634
10,268
13,366
12,960
12,469
12,117
102,338
99,559
94,771
94,001
89,235
99,025
77,740
93,353
78,164
87,187
70,653
82,219
65,945
77,141
61,017
388,577
65,658
377,718
373,599
367,434
45,466
389,736
40,569
378,823
36,418
379,028
31,619
369,879
27,047
398,214
22,231
388,429
17,216
378,645
12,400
375,324
7,599
366,391
382,091
377,106
374,446
371,786
369,126
358,259
348,700
346,128
343,560
341,000
336,287
333,745
331,202
328,670
325,632
323,099
320,568
318,036
315,505
325,954
912
326,480
360,004
356,541
375,884
374,181
377,806
378,345
375,330
372,014
395,546
391,447
387,289
383,171
379,070
377,290
411,757
407,752
401,103
401,103407,752411,757377,290379,070383,171387,289391,447395,546372,014375,330378,345377,806374,181375,884356,541360,004326,480912325,954315,505318,036320,568323,099325,632328,670331,202333,745336,287341,000343,560346,128348,700358,259369,126371,786374,446377,106382,091366,3917,599375,32412,400378,64517,216388,42922,231398,21427,047369,87931,619379,02836,418378,82340,569389,73645,466367,434373,599377,71865,658388,57761,01777,14165,94582,21970,65387,18778,16493,35377,74099,02589,23594,00194,77199,559102,33812,11712,46912,96013,36610,26810,63411,00010,06511,15510,09110,3244,3704,5334,4953,298
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,741
189,837
17,226
14,070
23,107
17,196
206,234
1,059,618
38,467
59,562
71,005
68,971
72,381
86,434
99,514
59,018
69,148
54,118
45,854
1,513,112
1,513,11245,85454,11869,14859,01899,51486,43472,38168,97171,00559,56238,4671,059,618206,23417,19623,10714,07017,226189,837169,741000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
159,076
162,712
116,605
88,228
159,369
153,163
141,110
165,576
279,468
340,206
312,283
347,138
371,977
503,686
591,887
501,743
612,916
593,264
535,371
449,199
502,705
488,543
503,380
569,947
560,900
435,987
487,402
383,890
544,531
459,711
698,207
616,732
762,355
583,754
755,648
524,726
590,270
596,487
670,264
726,926
577,239
432,294
851,487
671,109
872,344
666,797
815,726
1,175,788
1,217,355
882,864
837,769
859,148
953,833
1,266,250
1,168,053
1,193,872
1,150,783
1,022,633
1,065,179
323,736
444,546
423,308
355,717
449,965
283,351
305,600
393,600
448,738
413,208
457,599
430,463
563,531
645,820
619,881
633,229
834,837
632,973
650,569
621,326
672,274
644,864
738,621
679,076
1,415,112
1,317,093
1,361,998
1,456,936
1,748,282
1,561,109
1,600,915
1,525,407
1,653,437
1,653,4371,525,4071,600,9151,561,1091,748,2821,456,9361,361,9981,317,0931,415,112679,076738,621644,864672,274621,326650,569632,973834,837633,229619,881645,820563,531430,463457,599413,208448,738393,600305,600283,351449,965355,717423,308444,546323,7361,065,1791,022,6331,150,7831,193,8721,168,0531,266,250953,833859,148837,769882,8641,217,3551,175,788815,726666,797872,344671,109851,487432,294577,239726,926670,264596,487590,270524,726755,648583,754762,355616,732698,207459,711544,531383,890487,402435,987560,900569,947503,380488,543502,705449,199535,371593,264612,916501,743591,887503,686371,977347,138312,283340,206279,468165,576141,110153,163159,36988,228116,605162,712159,076
   > Total Current Liabilities 
134,077
148,580
103,605
88,229
159,368
153,163
114,465
139,176
248,068
278,807
248,243
281,387
271,369
357,808
444,369
374,126
485,300
470,647
442,754
449,027
502,532
488,371
503,178
569,745
560,728
435,535
487,230
383,718
544,359
459,538
698,035
614,259
759,904
500,227
672,147
441,250
506,819
592,961
666,763
723,450
573,789
428,868
848,086
658,719
828,996
553,692
702,663
637,821
679,066
344,247
298,819
349,857
444,198
756,264
657,710
682,978
639,519
1,009,953
1,061,653
322,599
443,446
421,887
354,220
425,593
239,017
261,182
292,219
330,071
293,378
328,053
300,811
453,731
524,368
545,292
557,922
748,913
549,373
570,375
543,859
601,488
574,882
662,313
599,614
1,316,560
1,220,237
1,267,534
1,365,085
1,657,669
1,473,622
1,514,855
1,451,428
1,585,952
1,585,9521,451,4281,514,8551,473,6221,657,6691,365,0851,267,5341,220,2371,316,560599,614662,313574,882601,488543,859570,375549,373748,913557,922545,292524,368453,731300,811328,053293,378330,071292,219261,182239,017425,593354,220421,887443,446322,5991,061,6531,009,953639,519682,978657,710756,264444,198349,857298,819344,247679,066637,821702,663553,692828,996658,719848,086428,868573,789723,450666,763592,961506,819441,250672,147500,227759,904614,259698,035459,538544,359383,718487,230435,535560,728569,745503,178488,371502,532449,027442,754470,647485,300374,126444,369357,808271,369281,387248,243278,807248,068139,176114,465153,163159,36888,229103,605148,580134,077
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000010020,00000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000010020,00000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
41,749
34,705
32,506
37,773
56,133
24,671
32,926
46,548
59,150
57,569
46,306
65,157
86,051
72,879
95,772
72,089
123,059
139,479
133,542
61,624
137,903
144,011
116,970
119,348
155,691
88,531
126,360
64,045
124,829
111,038
222,483
46,913
99,988
108,099
200,930
95,398
142,588
156,041
239,285
212,641
230,615
135,719
431,038
249,490
384,597
195,538
254,534
229,628
293,305
213,635
220,952
231,898
223,033
304,516
272,605
308,492
341,149
324,144
326,553
45,135
61,393
75,617
20,761
47,728
54,789
51,830
41,990
88,144
82,691
85,308
85,508
119,549
110,256
163,270
160,267
56,305
33,516
59,280
35,347
45,561
69,293
63,870
66,411
205,721
273,042
225,796
243,864
236,281
217,337
157,783
181,460
156,254
156,254181,460157,783217,337236,281243,864225,796273,042205,72166,41163,87069,29345,56135,34759,28033,51656,305160,267163,270110,256119,54985,50885,30882,69188,14441,99051,83054,78947,72820,76175,61761,39345,135326,553324,144341,149308,492272,605304,516223,033231,898220,952213,635293,305229,628254,534195,538384,597249,490431,038135,719230,615212,641239,285156,041142,58895,398200,930108,09999,98846,913222,483111,038124,82964,045126,36088,531155,691119,348116,970144,011137,90361,624133,542139,479123,05972,08995,77272,87986,05165,15746,30657,56959,15046,54832,92624,67156,13337,77332,50634,70541,749
       Other Current Liabilities 
64,728
95,775
56,099
28,456
50,519
88,992
78,039
33,128
57,096
49,413
85,258
90,397
39,967
78,929
62,597
32,037
62,241
55,168
73,212
45,041
115,083
93,496
96,344
107,343
171,037
91,779
96,870
45,569
155,530
84,500
111,873
203,346
236,116
108,128
187,217
171,852
160,231
171,920
142,478
285,809
152,174
93,149
172,048
209,229
139,399
128,154
218,129
208,193
215,761
110,612
72,867
92,959
196,165
174,449
250,106
249,486
173,370
156,699
705,099
257,465
352,053
256,269
216,402
287,865
184,227
209,353
250,229
241,926
210,687
115,385
168,240
134,426
123,329
74,619
28,379
204,408
477,342
155,980
453,266
243,782
448,182
248,945
460,906
416,404
881,463
302,119
1,026,488
533,557
1,156,813
466,440
18,512
84,572
84,57218,512466,4401,156,813533,5571,026,488302,119881,463416,404460,906248,945448,182243,782453,266155,980477,342204,40828,37974,619123,329134,426168,240115,385210,687241,926250,229209,353184,227287,865216,402256,269352,053257,465705,099156,699173,370249,486250,106174,449196,16592,95972,867110,612215,761208,193218,129128,154139,399209,229172,04893,149152,174285,809142,478171,920160,231171,852187,217108,128236,116203,346111,87384,500155,53045,56996,87091,779171,037107,34396,34493,496115,08345,04173,21255,16862,24132,03762,59778,92939,96790,39785,25849,41357,09633,12878,03988,99250,51928,45656,09995,77564,728
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,452
74,589
75,307
85,924
83,601
80,194
77,467
70,786
69,981
76,307
79,462
98,551
96,856
94,464
91,851
90,612
87,488
86,060
73,979
67,484
67,48473,97986,06087,48890,61291,85194,46496,85698,55179,46276,30769,98170,78677,46780,19483,60185,92475,30774,589121,452000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
1
0
26,645
26,400
26,400
26,399
29,040
29,070
29,071
29,219
29,220
180
179
180
180
172
173
172
202
202
172
452
172
172
172
173
172
2,473
2,451
3,527
3,501
3,476
3,451
3,526
3,501
3,476
3,450
3,426
3,401
12,390
13,348
13,105
13,063
12,967
12,904
12,842
12,778
12,718
12,654
12,592
12,529
12,655
12,592
12,680
3,526
1,137
1,100
1,422
1,497
24,372
24,334
24,418
31,380
48,668
49,830
59,547
58,538
59,800
71,452
74,589
75,307
85,924
83,601
80,194
77,467
70,786
69,575
75,950
79,150
95,761
93,427
92,266
90,344
89,437
86,596
83,854
0
0
0083,85486,59689,43790,34492,26693,42795,76179,15075,95069,57570,78677,46780,19483,60185,92475,30774,58971,45259,80058,53859,54749,83048,66831,38024,41824,33424,3721,4971,4221,1001,1373,52612,68012,59212,65512,52912,59212,65412,71812,77812,84212,90412,96713,06313,10513,34812,3903,4013,4263,4503,4763,5013,5263,4513,4763,5013,5272,4512,47317217317217217245217220220217217317218018017918029,22029,21929,07129,07029,04026,39926,40026,40026,645010000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
560
546
1,132
519
1,005
941
877
803
733
661
594
564
513
500
2,773
2,675
2,515
2,417
2,320
4,892
4,251
0
0
004,2514,8922,3202,4172,5152,6752,7735005135645946617338038779411,0055191,132546560000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
537,200
523,168
524,385
523,560
527,151
534,464
546,155
549,699
562,455
581,039
593,084
602,163
610,477
620,939
631,945
660,059
671,978
677,371
685,071
700,040
717,163
706,714
723,037
747,144
770,451
817,669
831,424
836,835
883,578
877,136
896,905
921,188
966,660
901,171
934,437
1,026,582
1,089,481
1,064,298
1,121,245
1,732,113
1,795,845
1,735,402
1,775,496
1,866,586
1,933,880
1,880,675
1,922,583
2,000,434
2,084,061
2,021,055
2,046,256
2,079,344
2,078,072
1,905,937
1,967,703
2,077,308
2,141,046
2,126,556
2,209,272
2,354,320
2,461,859
2,430,889
2,489,819
2,615,545
2,724,820
2,706,096
2,816,710
2,915,203
3,031,233
3,008,565
3,133,821
3,253,296
3,380,348
3,386,523
3,516,157
3,560,629
3,692,054
3,673,131
3,801,169
3,876,868
4,036,223
4,013,341
4,085,333
4,003,034
4,186,731
3,995,106
4,106,815
3,890,966
4,134,244
3,937,179
4,081,962
3,831,520
3,831,5204,081,9623,937,1794,134,2443,890,9664,106,8153,995,1064,186,7314,003,0344,085,3334,013,3414,036,2233,876,8683,801,1693,673,1313,692,0543,560,6293,516,1573,386,5233,380,3483,253,2963,133,8213,008,5653,031,2332,915,2032,816,7102,706,0962,724,8202,615,5452,489,8192,430,8892,461,8592,354,3202,209,2722,126,5562,141,0462,077,3081,967,7031,905,9372,078,0722,079,3442,046,2562,021,0552,084,0612,000,4341,922,5831,880,6751,933,8801,866,5861,775,4961,735,4021,795,8451,732,1131,121,2451,064,2981,089,4811,026,582934,437901,171966,660921,188896,905877,136883,578836,835831,424817,669770,451747,144723,037706,714717,163700,040685,071677,371671,978660,059631,945620,939610,477602,163593,084581,039562,455549,699546,155534,464527,151523,560524,385523,168537,200
   Common Stock
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
146,112
219,168
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
295,877
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
311,150
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
420,000
420,000
420,000
420,000
525,000
525,000
525,000
525,000
630,000
630,000
630,000
630,000
630,000
630,000
630,000
630,000
629,912
629,582
629,582
629,549
629,445
0
0
00629,445629,549629,582629,582629,912630,000630,000630,000630,000630,000630,000630,000630,000525,000525,000525,000525,000420,000420,000420,000420,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000311,150311,150311,150311,150311,150311,150311,150311,150311,150311,150311,150311,150311,150311,150295,877295,877295,877295,877295,877295,877295,877295,877295,877295,877295,877295,877295,877219,168146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112146,112
   Retained Earnings 
94,194
71,782
68,585
61,584
74,591
95,108
106,766
92,607
105,264
123,330
135,178
133,580
141,894
152,176
163,085
153,557
165,439
170,175
177,725
180,687
197,745
187,268
203,753
220,349
239,810
260,108
273,863
252,286
299,990
294,466
305,772
329,214
374,686
309,197
342,463
411,791
474,689
449,506
506,453
559,754
623,486
563,042
603,137
672,726
740,019
686,814
728,722
804,717
888,344
825,339
850,539
883,627
1,106,997
1,059,168
1,118,495
1,228,117
1,291,855
1,277,366
1,360,081
1,505,129
1,612,669
1,581,698
1,640,629
1,764,893
1,874,100
1,855,337
1,965,838
2,062,690
2,178,720
2,156,051
2,281,307
2,397,938
2,309,461
2,210,636
2,340,270
2,600,270
2,731,695
2,607,773
2,735,811
2,811,510
2,970,865
2,947,983
3,093,247
3,008,495
3,192,193
2,991,559
3,104,204
2,880,535
3,121,366
2,918,330
2,704,411
2,437,289
2,437,2892,704,4112,918,3303,121,3662,880,5353,104,2042,991,5593,192,1933,008,4953,093,2472,947,9832,970,8652,811,5102,735,8112,607,7732,731,6952,600,2702,340,2702,210,6362,309,4612,397,9382,281,3072,156,0512,178,7202,062,6901,965,8381,855,3371,874,1001,764,8931,640,6291,581,6981,612,6691,505,1291,360,0811,277,3661,291,8551,228,1171,118,4951,059,1681,106,997883,627850,539825,339888,344804,717728,722686,814740,019672,726603,137563,042623,486559,754506,453449,506474,689411,791342,463309,197374,686329,214305,772294,466299,990252,286273,863260,108239,810220,349203,753187,268197,745180,687177,725170,175165,439153,557163,085152,176141,894133,580135,178123,330105,26492,607106,76695,10874,59161,58468,58571,78294,194
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000-55,0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,390,102
Cost of Revenue-1,523,006
Gross Profit2,867,0962,867,096
 
Operating Income (+$)
Gross Profit2,867,096
Operating Expense-3,507,085
Operating Income883,017-639,989
 
Operating Expense (+$)
Research Development133,333
Selling General Administrative1,687,935
Selling And Marketing Expenses0
Operating Expense3,507,0851,821,268
 
Net Interest Income (+$)
Interest Income67,639
Interest Expense-6,980
Other Finance Cost-854
Net Interest Income59,805
 
Pretax Income (+$)
Operating Income883,017
Net Interest Income59,805
Other Non-Operating Income Expenses0
Income Before Tax (EBT)897,134883,017
EBIT - interestExpense = -6,980
708,292
715,271
Interest Expense6,980
Earnings Before Interest and Taxes (EBIT)0904,114
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax897,134
Tax Provision-130,470
Net Income From Continuing Ops766,664766,664
Net Income708,292
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-59,805
 

Technical Analysis of Jiangzhong Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangzhong Pharmaceutical Co Ltd. The general trend of Jiangzhong Pharmaceutical Co Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangzhong Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangzhong Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 26.29 > 25.70 > 24.75.

Tweet this
Jiangzhong Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangzhong Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangzhong Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangzhong Pharmaceutical Co Ltd. The current macd is 0.77522513.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangzhong Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jiangzhong Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jiangzhong Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangzhong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangzhong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangzhong Pharmaceutical Co Ltd. The current adx is 28.05.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jiangzhong Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Jiangzhong Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangzhong Pharmaceutical Co Ltd. The current sar is 24.06.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangzhong Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangzhong Pharmaceutical Co Ltd. The current rsi is 78.52. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Jiangzhong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangzhong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangzhong Pharmaceutical Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangzhong Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Jiangzhong Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangzhong Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangzhong Pharmaceutical Co Ltd. The current cci is 276.23.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Jiangzhong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangzhong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangzhong Pharmaceutical Co Ltd. The current cmo is 70.38.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangzhong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangzhong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangzhong Pharmaceutical Co Ltd. The current willr is -7.33752621.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Jiangzhong Pharmaceutical Co Ltd Daily Williams %R ChartJiangzhong Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangzhong Pharmaceutical Co Ltd.

Jiangzhong Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangzhong Pharmaceutical Co Ltd. The current atr is 0.82571051.

Jiangzhong Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangzhong Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangzhong Pharmaceutical Co Ltd. The current obv is 461,697,730.

Jiangzhong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangzhong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangzhong Pharmaceutical Co Ltd. The current mfi is 79.74.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangzhong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangzhong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangzhong Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Jiangzhong Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangzhong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5078.515
Ma 20Greater thanMa 5024.048
Ma 50Greater thanMa 10023.319
Ma 100Greater thanMa 20022.298
OpenGreater thanClose26.490
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangzhong Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangzhong Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangzhong Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangzhong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangzhong Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangzhong Pharmaceutical Co Ltd.

Receive notifications about Jiangzhong Pharmaceutical Co Ltd in your mailbox!